Innovative license for startup success

Sandia’s molybdenum-99 nuclear reactor concept provides an efficient, cost-effective way to produce enough Mo-99 to meet current world demand. Sandia’s licensing and legal teams worked with startup Eden Radioisotopes on a unique license structure customized for a company entering a highly regulated industry and requiring substantial investment. Its flexible structure enabled Eden to seek funding and permits to build a medical isotope production facility in New Mexico and will make the state a key player in meeting the world’s need for Mo-99. The licensing effort won a Federal Laboratory Consortium award. (1000, 11000)